Quest Diagnostics’s most recent trend suggests a bearish bias. One trading opportunity on Quest Diagnostics is a Bear Call Spread using a strike $60.00 short call and a strike $70.00 long call offers a potential 3.63% return on risk over the next 26 calendar days. Maximum profit would be generated if the Bear Call Spread were to expire worthless, which would occur if the stock were below $60.00 by expiration. The full premium credit of $0.35 would be kept by the premium seller. The risk of $9.65 would be incurred if the stock rose above the $70.00 long call strike price.
The 5-day moving average is moving down which suggests that the short-term momentum for Quest Diagnostics is bearish and the probability of a decline in share price is higher if the stock starts trending.
The 20-day moving average is moving down which suggests that the medium-term momentum for Quest Diagnostics is bearish.
The RSI indicator is at 28.54 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Quest Diagnostics
Your first trade for Tuesday
Mon, 21 Oct 2013 18:16:21 GMT
CNBC – The “Fast Money” traders share their final trades of the day.
FMHR Final Trade
Mon, 21 Oct 2013 16:59:00 GMT
CNBC – The FMHR traders reveal their final trades.
Quest Diagnostics Threatens Myriad’s Grip on BRCA Tests
Fri, 18 Oct 2013 17:48:14 GMT
Quest Diagnostics Management Discusses Q3 2013 Results – Earnings Call Transcript
Thu, 17 Oct 2013 17:01:13 GMT
Seeking Alpha – Stephen H. Rusckowski Thanks, Dan, and thanks, everyone, for joining us today. I’d like to start by taking us through the top line performance, share our thoughts on utilization and reimbursement trends …
Danaher Hits New High After Q3 Earnings Beat
Thu, 17 Oct 2013 15:27:00 GMT
Investor’s Business Daily – Danaher Hits New High After Q3 Earnings Beat
Also on Market Tamer…
Follow Us on Facebook